Ireland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
Ireland Diabetes Care Devices Investment Opportunities,Analysis and Forecasts to 2018Report Details:Published:September 2012No. of Pages: 69Price: Single User License – US$2500Ireland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018SummaryGlobal Markets Direct’s new report, “Ireland Diabetes Care Devices Investment Opportunities,Analysis and Forecasts to 2018” provides key market data on the Ireland Diabetes Care Devicesmarket. The report provides value (USD million), volume (units) and average price (USD) data foreach segment and sub-segment within two market categories – Glucose Monitoring and InsulinDelivery. The report also provides company shares and distribution shares data for each of theaforementioned market categories. The report is supplemented with global corporate-level profilesof the key market participants with information on company financials and pipeline products,wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by Global Markets Direct’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the Ireland Diabetes CareDevices market.- Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Sanofi, Novo NordiskA/S , Eli Lilly and Company , Bayer HealthCare AG and others.
Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Ireland Diabetes CareDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/195372-ireland-diabetes-care-devices-investment-opportunities-analysis-and-forecasts-to-2018.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 41.2 List of Figures 52 Introduction 72.1 What is This Report About? 73 Diabetes Care Devices In Ireland 83.1 Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Constant, 2004-2018 83.2 Diabetes Care Devices, Ireland, Company Share (2010-2011) 134 Glucose Monitoring In Ireland 154.1 Glucose Monitoring Overall Revenue, (2004-2018) 154.1.1 Blood Glucose Meters, Revenue (2004-2018) 194.2 Glucose Monitoring Overall Volume (2004-2018) 234.2.1 Blood Glucose Meters, Volume (2004-2018) 274.3 Glucose Monitoring Average Price (2004-2018) 294.4 Glucose Monitoring Distribution Share (2010-2011) 304.5 Glucose Monitoring, Ireland, Company Share (2010-2011) 315 Insulin Delivery In Ireland 335.1 Insulin Delivery Overall Revenue, (2004-2018) 335.1.1 Insulin Pens, Revenue (2004-2018) 375.1.2 Insulin Pumps, Revenue (2004-2018) 415.2 Insulin Delivery Overall Volume (2004-2018) 435.2.1 Insulin Pens, Volume (2004-2018) 475.2.2 Insulin Pumps, Volume (2004-2018) 515.3 Insulin Delivery Average Price (2004-2018) 535.4 Insulin Delivery Distribution Share (2010-2011) 54
5.5 Insulin Delivery, Ireland, Company Share (2010-2011) 556 Overview of Key Companies in Ireland Diabetes Care Devices Market 576.1 F. Hoffmann-La Roche Ltd. 576.1.1 Company Overview 576.2 LifeScan, Inc. 576.2.1 Company Overview 576.3 Sanofi 586.3.1 Company Overview 586.4 Novo Nordisk A/S 586.4.1 Company Overview 586.5 Eli Lilly and Company 596.5.1 Company Overview 596.6 Bayer HealthCare AG 596.6.1 Company Overview 596.7 Abbott Laboratories 606.7.1 Company Overview 606.8 Becton, Dickinson and Company 606.8.1 Company Overview 606.9 Medtronic, Inc. 616.9.1 Company Overview 616.10 Terumo Corporation 616.10.1 Company Overview 616.11 Animas Corporation 616.11.1 Company Overview 616.12 Nipro Corporation 626.12.1 Company Overview 627 Appendix 637.1 Global Markets Direct Research Methodology 637.2 Definitions of Markets Covered in the Report 647.2.1 Diabetes Care Devices 647.3 Secondary Research 677.4 Primary Research 677.5 Models 687.6 Forecasts 687.7 Expert Panel Validation 687.8 Currency Conversion 697.9 Contact Us 697.10 Disclaimer 691.1 List of TablesTable 1: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Constant, 2004-2018 8Table 2: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Constant, Historic, 2004-